Open AccessIntrahepatic Viral Kinetics During Direct-Acting Antivirals for Hepatitis C in Human Immunodeficiency Virus Coinfection: The AIDS Clinical Trials Group A5335S Substudy
Author(s) -
Ashwin Balagopal,
Laura Smeaton,
Jeffrey Quinn,
Charles S. Venuto,
Gene D. Morse,
Vincent Vu,
Beverly AlstonSmith,
Daniel E. Cohen,
Jorge SantanaBagur,
Donald D. Anthony,
Mark Sulkowski,
David Wyles,
Andrew H. Talal
Publication year - 2020
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jiaa126
Subject(s) - ombitasvir , dasabuvir , paritaprevir , hepatitis c virus , coinfection , medicine , ritonavir , hepatitis c , virology , liver biopsy , ribavirin , viral load , hepacivirus , immunology , gastroenterology , virus , biopsy , antiretroviral therapy
Direct-acting antivirals (DAAs) targeting hepatitis C virus (HCV) have revolutionized outcomes in human immunodeficiency virus (HIV) coinfection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom